- PackSize
- 50ug/100ug
- Target
- IL15
- Reactivity
- Human
- Applications
- ELISA, Functional assay, Research in vivo
- Host Species
- Mammalian Cells
- Isotype
- Fusion - [IL15RA (interleukin 15 receptor subunit alpha, CD215, IL-15RA)]2 - IGHG1 Fc (Fragment constant)
- Conjugate/Modification
- --
- Recommended Dilution Ratio
- --
- Composition
- 0.01M PBS, pH 7.4.
- Purification Process
- Protein A/G purified from cell culture supernatant.
- Purity
- >95% purity as determined by SDS-PAGE.
- storageCondition
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
- Clonality
- --
- Clone Number
- --
- Immunogen
- Mammalian Cells
- Alias
- IL15, IL-15, Interleukin-15
- Species
- --
- Gene ID-1
- P40933
- Uniprot
- --
- Background
- Inbakicept is a dimeric human IL-15 receptor alpha (IL-15 Ra) sushi domain/human IgG1 Fc fusion protein and is an IL-15 superagonist complex. Inbakicept is able to form complex N-803 (Nogapendekin alfa inbakicept) with the IL-15 antibody Nogapendekin alfa in a 1:2 ratio. N-803 mimics the function of IL-15 and amplifies anti-CD20 mAb-mediated NK cell responses and antibody-dependent cellular cytotoxicity (ADCC). N-803 also increases degranulation and IFNγ production in cells.<br>• Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer., PMID:35660135<br/>• Interleukin 15: A key cytokine for immunotherapy., PMID:27325459<br/>• IL-15 in the Combination Immunotherapy of Cancer., PMID:32508818<br/>• IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells., PMID:31277710<br/>• Interleukin-15 in autoimmunity., PMID:32919253<br/>• Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers., PMID:39604730<br/>• An engineered concealed IL-15-R elicits tumor-specific CD8+T cell responses through PD-1-cis delivery., PMID:36165896<br/>• IL-15, gluten and HLA-DQ8 drive tissue destruction in coeliac disease., PMID:32051586<br/>• Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect <i>in vivo</i>., PMID:37818365<br/>• Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy., PMID:34797911<br/>
- Tissue Expression
- --
- Signaling_pathway
- --
- Research Areas
- --